CEO Alex Grenier tells Proactive the Montreal, Canada-based logistics and supply chain company is opening a facility on Long Island, New York, that is FDA-compliant, and will be manufacturing medicinal cannabis to be used in 3rd-party products and then exported into Europe.

Grenier says the privately held company is shifting its focus away from providing pharmaceutical laboratory services to manufacturing and exporting cannabis to take part in the imminent need for regulatory compliance in the space.